534 Determinants of 5-Year Survival in Patients with Advanced NSCLC with PD-L1 ≥50% Treated with First Line Pembrolizumab Outside of Clinical Trials: Results from the Pembro-real 5Y Global Registry Alessio Cortellini , Edoardo Garbo , Leonardo Brunetti , Giuseppina Rita Di Fazio , Monica Loza , Carlo Genova , Ritujith Jayakrishnan , Michele Montrone , Mingjia Li , Lauren Young , Giulio Metro , Francesco Passiglia , Nichola O Awosika , Eleni Josephides , Bartlomiej Tomasik , Raffaele Giusti , Emilio Bria , Maximilian Rost , Gabriele Minuti , Francesca Mazzoni , Avinash Aujayeb , Alessandro Morabito , Alessandro Leonetti , Alfredo Addeo , Giannis Mountzios , Sukumar Kalvapudi , Eleni Karapanagiotou , Isabelle Monnet , Aida Piedra , Francesco Agustoni , Diego L Cortinovis , Teresa Gorria , Teresa Beninato , Laura Moliner , Federica Biello , Taher A Hejleh , Amin Nassar , Biagio Ricciuti Regular and Young Investigator Award Abstracts（2024）
AI 理解论文
溯源树
样例
